Obtenez 3 mois à 0,99 $/mois

OFFRE D'UNE DURÉE LIMITÉE
Page de couverture de Doctors Making A Difference

Doctors Making A Difference

Doctors Making A Difference

Auteur(s): Peter M. Crane MD
Écouter gratuitement

À propos de cet audio

 Not every doctor dreams of climbing the traditional ladder. Some dream of building their own. Doctors Making a Difference, hosted by Dr. Peter Crane, tells the stories we rarely hear, of physicians who dared to ask, “Is this all there is?” and then changed their lives to answer it. These are the moments after burnout, after bureaucracy, after sacrifice. When purpose called louder than protocol. Each week, listeners meet doctors who stepped off the expected path—into roles as entrepreneurs, advocates, creatives, and leaders redefining what it means to heal. They didn’t just survive medicine. They made it theirs.Copyright 2025 Doctors Making A Difference Développement personnel Finances personnelles Hygiène et mode de vie sain Réussite Troubles et maladies Économie
Épisodes
  • DMD #60 | Chronic Illness, Misdiagnosis & the Truth About Tick-Borne Disease with Dr. Susan Marra

    DMD #60 | Chronic Illness, Misdiagnosis & the Truth About Tick-Borne Disease with Dr. Susan Marra
    Dec 4 2025
    This episode is sponsored by Lightstone DIRECT. Lightstone DIRECT invites you to partner with a $12B AUM real estate institution as you grow your portfolio. Access the same single-asset multifamily and industrial deals Lightstone pursues with its own capital – Lightstone co-invests a minimum of 20% in each deal alongside individual investors like you. You’re an institution. Time to invest like one.–When Dr. Susan Marra graduated from naturopathic school, she expected to treat the usual mix of fatigue, hormone imbalance, and stress. Instead, she walked into a wave of patients with strange, multisystem illnesses no textbook had prepared her for. Migrating joint pain. Seven-day migraines. Brain fog. Dysbiosis. Symptoms crossing multiple organ systems.Her instinct told her something bigger was happening — and she was right.That intuition led her to Dr. Bernard Raxlen, one of the earliest clinicians to recognize chronic Lyme disease. She went on to train with world experts Dr. Richard Horowitz and Dr. Charles Ray Jones, immersing herself in complex tick-borne illness long before mainstream medicine acknowledged it.And then she got infected herself.A tick — likely carried in by her yellow lab — transmitted Lyme and Bartonella. She lost vision in her right eye for six months and required IV antibiotics, steroids, and years of recovery. That lived experience, combined with decades of clinical immersion, transformed her into one of the most respected Lyme specialists in the country.Today, after treating 9,000+ patients, Dr. Marra joins Dr. Peter Crane to dismantle the myths surrounding Lyme, the limitations of standard testing, the rise of co-infections, and why so many patients with “mystery symptoms” are actually living with chronic vector-borne illness.This is an eye-opening conversation every physician should hear.HighlightsHow a wave of multisystem complaints led Dr. Marra to uncover the true prevalence of tick-borne illness.Why nine out of ten patients she tested in Connecticut were Lyme-positive.The difference between IDSA and ILADS—and why it affects diagnosis.Dr. Marra’s personal battle with Lyme & Bartonella, including temporary vision loss.The modern reality: patients rarely have “just Lyme”—co-infections are now the norm.Why standard labs miss most infections—and which specialty labs offer reliable results.Cutting-edge diagnostics: PCR, FISH testing, and antibody panels.The evolving treatment landscape: antibiotics, antiparasitics, methylene blue, Dapsone, botanical protocols, and more.The growing concern of transfusion-acquired infections and congenital Lyme.How physicians can recognize tick-borne disease in patients with long, confusing symptom lists.Top 3 Takeaways1. Multisystem symptoms should trigger suspicion.If a patient presents with a long list of symptoms across multiple organ systems, think vector-borne illness.2. Standard labs miss the majority of cases.Specialized labs (e.g., IGeneX, Armin, T-Labs) dramatically increase diagnostic accuracy.3. Co-infections—not single infections—are the new norm.The modern patient rarely presents with isolated Lyme; Babesia, Bartonella, and other pathogens are commonly intertwined.About Dr. Susan MarraDr. Susan Marra is a naturopathic physician with 27 years of experience specializing in chronic Lyme disease and complex tick-borne illness. Trained by legendary clinicians including Dr. Richard Horowitz and Dr. Charles Ray Jones, Dr. Marra blends rigorous clinical training with lived experience as a Lyme survivor. She has treated more than 9,000 patients, serves on multiple research boards, and is known for her precision-based diagnostic approach, combining specialty testing with a deep understanding of chronic infection and epigenetics.Website: drsusanmarra.comAbout the Host:Dr. Peter Crane is a board-certified physician, educator, and storyteller with a heart for service and a calling to spotlight doctors who make a difference—in their communities, in medicine, and in the lives they touch.Through Doctors Making a Difference, he brings you into intimate conversations with physicians who have overcome challenges, redefined success, and found purpose in and beyond the clinic. His goal is simple: to help more doctors stay in medicine by showing them what's possible.About the Show:Doctors Making a Difference is more than a podcast—it’s a movement to highlight the good, the gritty, and the deeply human side of medicine.In every episode, Dr. Peter Crane interviews physicians whose stories defy the script. From burnout recovery to bold career pivots, health challenges to quiet leadership, this show honors the truth that healing begins with connection—and doctors, too, deserve to be whole.Visit: doctorsmakingadifference.comLMC Series Note:Living with Metastatic Cancer (LMC) explores the science, decisions, and day-to-day realities of life with advanced disease—through candid physician–patient conversations. The Doctors ...
    Voir plus Voir moins
    40 min
  • DMD #59 | The $500B Problem Nobody Told Doctors About — Until Dr. Ramlall Did

    DMD #59 | The $500B Problem Nobody Told Doctors About — Until Dr. Ramlall Did
    Nov 27 2025
    This episode is sponsored by Lightstone DIRECT. Lightstone DIRECT invites you to partner with a $12B AUM real estate institution as you grow your portfolio. Access the same single-asset multifamily and industrial deals Lightstone pursues with its own capital – Lightstone co-invests a minimum of 20% in each deal alongside individual investors like you. You’re an institution. Time to invest like one.–When a psychologist told Dr. Kumar Ramlall that his son ranked “third worst out of 1,000,” he refused to accept the story being handed to him. That moment — that instinct to rewrite the script — became a turning point not just for his son, but for his entire career.In this powerful episode of Doctors Making a Difference, Dr. Peter Crane speaks with Dr. Ramlall about a life shaped by adversity, reinvention, and an unwavering belief that outcomes are not predetermined.Raised in Guyana and once a high school dropout, Dr. Ramlall rebuilt his life to become a physician, academic leader, and founder of a provincial pediatric pulmonary service in Saskatchewan. But nothing prepared him for raising a son with severe autism. The journey to help Amit thrive led the family around the world and ultimately inspired the creation of The Chintan Project, a global human-behavior consultancy built from Amit’s own writing and thinking.That same drive to challenge conventional wisdom later led Dr. Ramlall to uncover one of medicine’s biggest hidden financial traps: the $500 billion that physicians collectively lose each year due to out-of-network underpayments and missed arbitration windows under the No Surprises Act. Through his work with CAG Recovery, he’s helping doctors recover 8–12x what insurance companies initially offer — money that keeps practices alive and independent.This episode is about more than medicine. It’s about protecting your family, your legacy, and the profession itself by learning how to fight back.HighlightsThe devastating moment a psychologist ranked his son “third worst” — and the decision to rewrite the script anyway.How a homemade letterboard helped Amit read thousands of books and write manuscripts that now power a global consultancy.Why Dr. Ramlall walked away from academia to protect his son’s intellectual property from university ownership claims.The origin story of The Chintan Project — and how a child once expected to struggle now inspires leaders worldwide.The shocking truth about out-of-network payments: 90% of eligible cases go unfiled, leaving billions on the table.How CAG Recovery has reclaimed over $1.18B for physicians through the federal arbitration process.The tight timelines and intentionally confusing processes insurers rely on to avoid paying doctors fairly.Why protecting the business of medicine is essential for protecting the practice of medicine.Top 3 TakeawaysIf you don’t like the movie, change the script.Your circumstances don’t define your ending — your decisions do.Doctors are losing staggering amounts of money without realizing it.Insurance companies leverage complex systems most physicians don’t even know exist.Protecting your financial foundation is an ethical obligation.Because when practices fail, patients lose access to care.About Dr. Kumar RamlallPhysician, entrepreneur, and co-founder of The Chintan Project, Dr. Ramlall blends medical expertise with deep human-behavior insight. From building a provincial service in Saskatchewan to creating a global advisory firm rooted in his son’s extraordinary thinking, Dr. Ramlall’s mission is to help both families and physicians reclaim what’s rightfully theirs — in life, work, and purpose.About the Host:Dr. Peter Crane is a board-certified physician, educator, and storyteller with a heart for service and a calling to spotlight doctors who make a difference—in their communities, in medicine, and in the lives they touch.Through Doctors Making a Difference, he brings you into intimate conversations with physicians who have overcome challenges, redefined success, and found purpose in and beyond the clinic. His goal is simple: to help more doctors stay in medicine by showing them what's possible.About the Show:Doctors Making a Difference is more than a podcast—it’s a movement to highlight the good, the gritty, and the deeply human side of medicine.In every episode, Dr. Peter Crane interviews physicians whose stories defy the script. From burnout recovery to bold career pivots, health challenges to quiet leadership, this show honors the truth that healing begins with connection—and doctors, too, deserve to be whole.Visit: doctorsmakingadifference.com The Doctors Making a Difference Podcast is for informational purposes only and does not substitute for medical, legal, or professional advice. Always consult appropriate experts regarding your unique circumstances. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal...
    Voir plus Voir moins
    39 min
  • LMC #58 | Joel Horowitz & Dr. Gina D’Amato on Hope, Research, and the Fight Against Solitary Fibrous Tumor

    LMC #58 | Joel Horowitz & Dr. Gina D’Amato on Hope, Research, and the Fight Against Solitary Fibrous Tumor
    Nov 20 2025
    This episode is sponsored by Lightstone DIRECT. Lightstone DIRECT invites you to partner with a $12B AUM real estate institution as you grow your portfolio. Access the same single-asset multifamily and industrial deals Lightstone pursues with its own capital – Lightstone co-invests a minimum of 20% in each deal alongside individual investors like you. You’re an institution. Time to invest like one.–When New York entrepreneur Joel Horowitz was diagnosed with solitary fibrous tumor (SFT) in 2018, he didn’t just enter treatment — he entered the fight.In this powerful conversation, Dr. Peter Crane is joined by Joel and renowned sarcoma specialist Dr. Gina D’Amato, clinical lead of the Sarcoma Program at Sylvester Comprehensive Cancer Center at the University of Miami. Together, they share the story of how one patient’s passion and generosity helped ignite a groundbreaking research initiative that is already reshaping what’s possible for people living with SFT.Joel recounts his diagnosis, his exposure history as a 9/11 survivor, and the moment he realized he wanted to fund the team he believed could change the future of this disease. Dr. D’Amato shares the extraordinary progress underway — from engineered mouse models and molecular profiling to a newly launched global patient registry designed to finally bring answers to a cancer so rare that most oncologists may see only one case in their career.This episode is about science, yes — but even more, it’s about hope, human connection, and the belief that when patients, clinicians, and researchers unite, lives can change.Highlights💬 A Patient’s Mission — How Joel transformed fear into momentum, becoming a key force behind a major research initiative.🧬 Behind the Research — Dr. D’Amato explains the three-pronged strategy: molecular profiling, engineered mouse models, and a global SFT registry.🌍 Registry for the World — Why solitaryfibroustumor.org is a breakthrough moment for patients, families, and clinicians.🔥 Matching Hope With Action — Joel’s commitment to match up to $100,000 in donations to accelerate clinical trial development.🏥 The Dream Team — How collaboration across Miami, New York, Spain, and Texas is pushing SFT research into new territory.Top 3 TakeawaysConnection Changes Outcomes.Progress accelerates when patients, researchers, and clinicians move together with shared purpose.Data Is Power.The new global registry is the key to understanding SFT and developing targeted, effective treatments.Hope Requires Movement.Funding, awareness, and participation from patients and families directly shape the research that may save lives.About Joel HorowitzJoel Horowitz is a New York entrepreneur and longtime advocate for solitary fibrous tumor research. After surviving 9/11 and later receiving an SFT diagnosis, Joel chose not only to fight his own disease but also to support the scientific team he believed could change the future for others.His philanthropic leadership created the Horowitz Solitary Fibrous Tumor Initiative, funding molecular research, mouse models, and the global SFT patient registry. His commitment continues today as he pledges to match up to $100,000 in new donations to advance clinical trials.About Dr. Gina D’AmatoGina D’Amato, MD is a nationally recognized sarcoma medical oncologist and Professor of Clinical Medicine at the Sylvester Comprehensive Cancer Center at the University of Miami. She serves as the Medical Director of the Comprehensive Treatment Unit, Assistant Director of Clinical Research, and the Administrator of the Horowitz Solitary Fibrous Tumor Initiative Fund, a program accelerating research and clinical discovery for patients living with solitary fibrous tumor (SFT).Research Fund: https://development.miami.edu/page.aspx?pid=383&id=ec01162f-1d17-4c44-89d6-addb185e07b5A University of Miami alumna from undergraduate training through medical school and residency, Dr. D’Amato completed her hematology/oncology fellowship at the Moffitt Cancer Center, where she trained under world-renowned sarcoma leaders including Dr. Trent. For more than two decades, she has led and contributed to numerous Phase 1–3 clinical trials through the National Cancer Institute and industry partners, and she remains a dedicated educator through her leadership in the Oncology Pathway at the Miller School of Medicine.Dr. D’Amato oversees multiple arms of the SFT research initiative — including molecular profiling, engineered mouse models, and the newly launched Solitary Fibrous Tumor Patient Registry, now open globally.Registry: https://www.solitaryfibroustumor.org/With more than 25 peer-reviewed publications, NIH-funded research, and deep expertise in connective tissue oncology, Dr. D’Amato is widely regarded for her scientific leadership, compassionate patient care, and commitment to advancing treatment options for individuals facing rare sarcomas.About the Host:Dr. Peter Crane is a ...
    Voir plus Voir moins
    41 min
Pas encore de commentaire